Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.
J. Gen. Virol.85, 2407-2419 (2004)
Open Access Green as soon as Postprint is submitted to ZB.